A powerful whole
organism model for accelerating ageing research
Fast therapeutic insights with the in vivo data you need
We help our global biotech partners gain early in vivo advances to inform and enrich their drug and therapeutic pipeline in short timeframes (weeks). We combine the inherent advantages of C. elegans as a model organism, with our world-leading expertise for validated, regulation-free testing with human translatability 1-6. We effectively build on in vitro studies, de-risk your project, and reduce the need for mammalian testing.
Our unique automated WormGazerTM technology provides rich multi-end point in vivo data to help you generate IP for your therapeutics. You partner with our interdisciplinary team who bring 80+ years joint experience to enable the optimal assay design using C. elegans as a model.
We work efficiently to bring you diverse data to meet your requirements for efficacy, early toxicology, phenotypic and functional end-points, drug combinations, mechanism of action, target validation and identification.
✓ De-risk and reduce rodent testing and regulation, saving time and resources
✓ A validated1-6, cheaper, 3R compliant model for acute and chronic drug testing
✓ Fast, rich data in weeks, with unique automated WormGazerTM technology
✓ Bespoke CRO assay development and proof of concept studies
✓ Expert interdisciplinary team with 80+ years joint experience as partners
✓ Seamless and collaborative approach to replicate in-house R&D✓ Well-structured, robust data for all in-house formats, publication, patents and investors
Five Alarm Bio, a UK drug discovery startup focussing on the underlying mechanisms of ageing to develop therapeutics for age-related disease, works with Magnitude Biosciences to test their compound, FAB001, to test their hypothesis on the nature of ageing.
“We have formed an incredible partnership, …with novel information on our formulations. All of this will be reflected in the publications of several papers and the filing of several patents. We hope to maintain this collaboration in future projects and keep developing new formulations to help human health.”
Gerald Dard, Managing Director, AB Biotek HNH
SERVICES
Contract lab services for
your research area
Sign up to our newsletter today, to get access to the latest company and industry news